Literature DB >> 12525202

Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction.

Sam M Wiseman1, Thom R Loree, Wesley L Hicks, Nestor R Rigual, Janet S Winston, Donfeng Tan, Garth R Anderson, Daniel L Stoler.   

Abstract

BACKGROUND: In thyroid tumors, the coexistence of well- and poorly differentiated tumor types has led to the hypothesis that poorly differentiated thyroid tumors develop from well-differentiated thyroid tumors. By evaluating the genomic instability of histologically distinct but coexisting tumor foci, this study aimed to develop an improved understanding of thyroid tumorigenesis and tumor evolution.
DESIGN: Laser capture microdissection (LCM) was carried out on archival formalin-fixed, paraffin-embedded sections from a tumor containing foci of classic papillary thyroid cancer and anaplastic thyroid cancer. DNA was extracted from each microdissected tumor focus. In addition, cryopreserved bulk normal and neoplastic thyroid tissue underwent DNA extraction. All DNA samples were subsequently evaluated for genomic instability by means of inter-simple sequence repeat polymerase chain reaction.
RESULTS: The LCM DNA from each archival paraffin-embedded tumor focus demonstrated unique patterns of banding as compared with the cryopreserved tumor and normal tissue DNA. Thus, intratumoral variability in genomic instability was observed. Comparison of inter-simple sequence repeat polymerase chain reaction patterns of LCM DNA from adjacent foci of papillary and anaplastic tumors showed conserved genome alterations.
CONCLUSIONS: At the genome level, thyroid tumors may be highly heterogeneous. The intratumoral histologic heterogeneity observed in thyroid neoplasms reflects genetically heterogeneous underlying tumor cell populations that are demonstrated by the observed differences in their rates and extents of genomic instability. The conserved genomic alterations in the microdissected papillary and anaplastic foci suggest intratumoral evolution, with transformation of a preexisting papillary tumor to anaplastic carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12525202     DOI: 10.1001/archotol.129.1.96

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

1.  Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.

Authors:  Moira Ragazzi; Federica Torricelli; Benedetta Donati; Alessia Ciarrocchi; Dario de Biase; Giovanni Tallini; Eleonora Zanetti; Alessandra Bisagni; Elisabetta Kuhn; Davide Giordano; Andrea Frasoldati; Simonetta Piana
Journal:  Virchows Arch       Date:  2020-07-18       Impact factor: 4.064

2.  Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.

Authors:  Hop S Tran Cao; Sharmeela Kaushal; Cynthia S Snyder; Weg M Ongkeko; Robert M Hoffman; Michael Bouvet
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

Review 3.  Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid.

Authors:  Jorge Albores-Saavedra; Kelley Carrick
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Anaplastic transformation of differentiated thyroid carcinoma.

Authors:  Gamal Khairy
Journal:  Int J Health Sci (Qassim)       Date:  2009-01

5.  Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers.

Authors:  Masamitsu Onda; Hisaki Nagai; Akira Yoshida; Shizuyo Miyamoto; Shin-Ichi Asaka; Junko Akaishi; Keisuke Takatsu; Mitsuji Nagahama; Kouichi Ito; Kazuo Shimizu; Mitsuru Emi
Journal:  J Hum Genet       Date:  2004-04-29       Impact factor: 3.172

6.  Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer.

Authors:  Indira Prabakaran; Jillian R Grau; Robert Lewis; Douglas L Fraker; Marina A Guvakova
Journal:  J Thyroid Res       Date:  2011-10-20

7.  Concurrent Anaplastic and Papillary Thyroid Carcinomas: A Case Report.

Authors:  Samara Skwiersky; Gil Hevroni; Gurbaj Singh; Lisel Hope; Tahmineh Haidary; Moro O Salifu; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2020-04-22

8.  The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.

Authors:  Katayoon Kasaian; Sam M Wiseman; Blair A Walker; Jacqueline E Schein; Yongjun Zhao; Martin Hirst; Richard A Moore; Andrew J Mungall; Marco A Marra; Steven J M Jones
Journal:  BMC Cancer       Date:  2015-12-18       Impact factor: 4.430

9.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

10.  Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.

Authors:  Huiling He; Wei Li; Dayong Wu; Rebecca Nagy; Sandya Liyanarachchi; Keiko Akagi; Jaroslaw Jendrzejewski; Hong Jiao; Kevin Hoag; Bernard Wen; Mukund Srinivas; Gavisha Waidyaratne; Rui Wang; Anna Wojcicka; Ilene R Lattimer; Elzbieta Stachlewska; Malgorzata Czetwertynska; Joanna Dlugosinska; Wojciech Gierlikowski; Rafal Ploski; Marek Krawczyk; Krystian Jazdzewski; Juha Kere; David E Symer; Victor Jin; Qianben Wang; Albert de la Chapelle
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.